Avastin Information

Avastin Information avastin Avastin Injections Are Reported to Cause Blindness At least 16 people in two states have gotten severe eye infections, and some have been avastin Avastin is the brand name for the anti-cancer medication bevacizumab, which belongs to a group of drugs called monoclonal antibodies

avastin The recommended dose of Avastin is 10 mgkg of body weight given once every 2 weeks or 15 mgkg of body weight given once every 3 weeks as an intravenous

avastin In 1997, clinical trials of Avastin began The main trial upon which FDA approval was based was a Phase III trial involving 813 patients The Bevacizumab is a type of targeted therapy called an angiogenesis inhibitor US Brand Name Alymsys Avastin Mvasi Zirabev FDA Approved Yes